Ruboxistaurin in New York Heart Failure Classification III-IV Patients

NCT02769611 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No funding

Conditions

Heart Failure

Interventions

DRUG: Ruboxistaurin

Sponsor

University of Tennessee

Collaborators

[object Object]